Clinical Trial Update: Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation

View source ↗

Summary

An open-label study of zonisamide for epilepsy in patients with intellectual disability has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental Disability
• Epilepsy
• Intellectual Disability

Drugs mentioned

• Zonegran (zonisamide)

Snippet

Sponsor: Northwell Health | Conditions: Epilepsy, Mental Retardation | Status: COMPLETED